PATRICK NUGENT: Open Payments
NPI 1962048702 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,137 in 19 payments from 10 companies in 2025. Trend: 2023 $370 · 2024 $345 · 2025 $1,137
Food & beverage: $1,137
| Company | Payments | Amount |
|---|---|---|
| SANOFI-AVENTIS U.S. LLC | 6 | $378 |
| Daiichi Sankyo Inc. | 4 | $210 |
| Novocure Inc. | 1 | $132 |
| Regeneron Healthcare Solutions, Inc. | 1 | $125 |
| Eisai Inc. | 1 | $122 |
| GENZYME CORPORATION | 2 | $68 |
| Janssen Biotech, Inc. | 1 | $33 |
| AstraZeneca Pharmaceuticals LP | 1 | $29 |
| SOBI, INC | 1 | $23 |
| BeOne Medicines USA, Inc. | 1 | $17 |
Products named: REZUROCK, Optune Gio, LYNOZYFIC, Lenvima, SARCLISA, Enhertu, DARZALEX, DATROWAY.
Industry payments across FL — which companies pay providers there.
